JP2008535909A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008535909A5 JP2008535909A5 JP2008506051A JP2008506051A JP2008535909A5 JP 2008535909 A5 JP2008535909 A5 JP 2008535909A5 JP 2008506051 A JP2008506051 A JP 2008506051A JP 2008506051 A JP2008506051 A JP 2008506051A JP 2008535909 A5 JP2008535909 A5 JP 2008535909A5
- Authority
- JP
- Japan
- Prior art keywords
- ccr2
- molecule
- mcp
- amino acid
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67147605P | 2005-04-15 | 2005-04-15 | |
| PCT/IL2006/000454 WO2006109301A2 (en) | 2005-04-15 | 2006-04-10 | Molecules and methods of using same for treating mcp-1/ccr2 associated diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008535909A JP2008535909A (ja) | 2008-09-04 |
| JP2008535909A5 true JP2008535909A5 (enExample) | 2009-04-02 |
Family
ID=36688002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008506051A Pending JP2008535909A (ja) | 2005-04-15 | 2006-04-10 | Ｍｃｐ−１／ｃｃｒ２関連疾患を治療するための分子およびその使用方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8388962B2 (enExample) |
| EP (1) | EP1871798B1 (enExample) |
| JP (1) | JP2008535909A (enExample) |
| CN (1) | CN101160323A (enExample) |
| AT (1) | ATE445644T1 (enExample) |
| AU (1) | AU2006233927A1 (enExample) |
| CA (1) | CA2597789A1 (enExample) |
| DE (1) | DE602006009786D1 (enExample) |
| ES (1) | ES2333358T3 (enExample) |
| MX (1) | MX2007010484A (enExample) |
| WO (1) | WO2006109301A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2333358T3 (es) | 2005-04-15 | 2010-02-19 | Rappaport Family Institute For Research In The Medical Sciences | Moleculas y metodos de uso de las mismas para el tratamiento de enfermedades asociadas con mcp-1/ccr2. |
| WO2007100920A2 (en) * | 2006-03-01 | 2007-09-07 | The Regents Of The University Of Michigan | Diagnosis and treatment of prostate cancer |
| US20100291677A1 (en) | 2007-08-24 | 2010-11-18 | Keio University | Reducer of immunosuppression by tumor cell and antitumor agent using the same |
| CN102370981B (zh) * | 2010-08-11 | 2014-07-16 | 中国科学院上海生命科学研究院 | 防治神经退行性疾病的试剂和方法 |
| KR20160036564A (ko) * | 2013-08-06 | 2016-04-04 | 고쿠리쓰다이가쿠호진 규슈다이가쿠 | 유기산 중합체를 유효 성분으로 하는 암 세포의 생착 예방 또는 생착 억제를 위한 의약 |
| NO2776305T3 (enExample) | 2014-04-23 | 2018-01-27 | ||
| CN107362353A (zh) * | 2016-05-11 | 2017-11-21 | 上海长海医院 | 一种去势抵抗的前列腺癌相关的药物靶点及其应用 |
| KR102308102B1 (ko) * | 2018-05-18 | 2021-10-07 | 가톨릭대학교 산학협력단 | Ccr2를 유효성분으로 포함하는 골질환의 예방 또는 치료용 조성물 |
| KR102308099B1 (ko) * | 2019-11-15 | 2021-10-01 | 가톨릭대학교 산학협력단 | Soluble CCR2 발현 유도된 줄기세포를 유효성분으로 포함하는 골질환의 예방 또는 치료용 조성물 |
| US12527842B2 (en) * | 2019-11-15 | 2026-01-20 | The Catholic University Of Korea Industry-Academic Cooperation Foundation | Composition for preventing or treating bone diseases comprising CCR2 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3532570B2 (ja) * | 1994-01-13 | 2004-05-31 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 哺乳類単球化学誘引物質タンパク質レセプター |
| SE9600820D0 (sv) * | 1996-03-01 | 1996-03-01 | Pharmacia Ab | Antibodies and their use |
| US6528625B1 (en) | 1996-10-28 | 2003-03-04 | Millennium Pharmaceuticals, Inc. | Anti-CCR5 antibodies and kits comprising same |
| JP2003523744A (ja) * | 2000-02-09 | 2003-08-12 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | Ｃｃｒ５に対する抗体 |
| FR2828102B1 (fr) * | 2001-03-28 | 2004-07-09 | Ifc Sa | Utilisation des lipoaminoacides dans une composition pharmaceutique comme promoteur et systeme disperse a usage pharmaceutique contenant de tels composes |
| KR100453877B1 (ko) * | 2001-07-26 | 2004-10-20 | 메덱스젠 주식회사 | 연쇄체화에 의한 면역 글로블린 융합 단백질의 제조 방법 및 이 방법에 의해 제조된 ＴＮＦＲ/Ｆｃ 융합 단백질, 상기 단백질을 코딩하는 ＤＮＡ, 상기 ＤＮＡ를 포함하는벡터, 및 상기 벡터에 의한 형질전환체 |
| JP4823060B2 (ja) | 2003-07-24 | 2011-11-24 | アムジェン インコーポレイテッド | Ｔｗｅａｋ受容体のマルチマー化およびオリゴマー化可溶性断片に関する組成物および方法 |
| IL157398A0 (en) | 2003-08-14 | 2004-02-19 | Hadasit Med Res Service | Pharmaceutical compositions comprising ccr5 antagonists |
| GB2423472A (en) | 2003-12-11 | 2006-08-30 | Univ Yale | Methods and compositions relating to ccr5 antagonist,ifn-&gammed;and il-13 induced inflammation |
| US20050215543A1 (en) | 2004-03-24 | 2005-09-29 | Pin-Fang Lin | Methods of treating HIV infection |
| ES2333358T3 (es) | 2005-04-15 | 2010-02-19 | Rappaport Family Institute For Research In The Medical Sciences | Moleculas y metodos de uso de las mismas para el tratamiento de enfermedades asociadas con mcp-1/ccr2. |
-
2006
- 2006-04-10 ES ES06728255T patent/ES2333358T3/es not_active Expired - Lifetime
- 2006-04-10 WO PCT/IL2006/000454 patent/WO2006109301A2/en not_active Ceased
- 2006-04-10 JP JP2008506051A patent/JP2008535909A/ja active Pending
- 2006-04-10 AU AU2006233927A patent/AU2006233927A1/en not_active Abandoned
- 2006-04-10 EP EP06728255A patent/EP1871798B1/en not_active Expired - Lifetime
- 2006-04-10 US US11/883,725 patent/US8388962B2/en not_active Expired - Fee Related
- 2006-04-10 CA CA002597789A patent/CA2597789A1/en not_active Abandoned
- 2006-04-10 DE DE602006009786T patent/DE602006009786D1/de not_active Expired - Lifetime
- 2006-04-10 MX MX2007010484A patent/MX2007010484A/es active IP Right Grant
- 2006-04-10 CN CNA2006800125405A patent/CN101160323A/zh active Pending
- 2006-04-10 AT AT06728255T patent/ATE445644T1/de not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Thordarson et al. | Well-defined protein–polymer conjugates—synthesis and potential applications | |
| Deng et al. | Inflammation‐instructed hierarchical delivery of IL‐4/miR‐21 orchestrates osteoimmune microenvironment toward the treatment of rheumatoid arthritis | |
| Lu et al. | N-trimethylsilyl amines for controlled ring-opening polymerization of amino acid N-carboxyanhydrides and facile end group functionalization of polypeptides | |
| JP2023103456A5 (enExample) | ||
| WO2007001422A3 (en) | High affinity antibodies against hmgb1 and methods of use thereof | |
| WO2007076200A3 (en) | Antagonists of hmgb1 and/or rage and methods of use thereof | |
| JP2008538506A5 (enExample) | ||
| JP2010532997A5 (enExample) | ||
| Ten Brummelhuis et al. | Orthogonal multifunctionalization of random and alternating copolymers | |
| Sun et al. | Thiol Michael addition reaction: a facile tool for introducing peptides into polymer‐based gene delivery systems | |
| JP2010527607A5 (enExample) | ||
| JP2002512983A5 (enExample) | ||
| JP2008523083A5 (enExample) | ||
| Klok et al. | Dendritic− graft polypeptides | |
| MX2007013031A (es) | Agentes terapeuticos de peptidos de toxina. | |
| JP2017536098A5 (enExample) | ||
| JP2004532893A (ja) | イオン化可能な内核を持つ単分子の高分子ミセル | |
| JP2016521688A5 (enExample) | ||
| JP2017500285A5 (enExample) | ||
| JP2010503630A5 (enExample) | ||
| Scorciapino et al. | Antimicrobial peptidomimetics: reinterpreting nature to deliver innovative therapeutics | |
| JP2008539252A5 (enExample) | ||
| Ghosh et al. | Noncovalent template-assisted mimicry of multiloop protein surfaces: assembling discontinuous and functional domains | |
| JP2009120969A5 (enExample) | ||
| RU2018127330A (ru) | Композиция, включающая агонист рецептора glp-1 и агонист глюкагонового рецептора, и ее применение |